Home
Bliss Gvs Pharma Ltd 52 Week Low

Bliss GVS Pharma Ltd
NSE: BLISSGVS
YEARLOW
Key Highlights
- The 52 Week Low of Bliss GVS Pharma Ltd is ₹ 92.25 as of 02 Apr 25 .
Company Fundamentals for Bliss GVS Pharma Ltd
Market Price of Bliss GVS Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
02 Apr 2025 | 120 |
01 Apr 2025 | 119.25 |
28 Mar 2025 | 117.55 |
27 Mar 2025 | 119.4 |
26 Mar 2025 | 121.1 |
25 Mar 2025 | 124.2 |
24 Mar 2025 | 122.85 |
21 Mar 2025 | 122.8 |
20 Mar 2025 | 120.85 |
19 Mar 2025 | 119.9 |
Asset Value vs Market Value of Bliss GVS Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Bliss GVS Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Bliss GVS Pharma Ltd
Historical Net Profit of Bliss GVS Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd News Hub
Bliss GVS Pharma to table results
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 October 2024. Po
Read more
18 Oct 24
Bliss GVS Pharma consolidated net profit declines 42.66% in the September 2024 quarter
Net profit of Bliss GVS Pharma declined 42.66% to Rs 24.26 crore in the quarter ended September 2024
Read more
25 Oct 24
Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP
Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With this allotme
Read more
04 Oct 24
Bliss GVS Pharma schedules board meeting
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Po
Read more
22 Jan 25